about
DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity and migration of melanoma cells as subunits of ElongatorEffect of non-steroidal anti-inflammatory drugs on amyloid-beta formation and macrophage activation after platelet phagocytosisThe c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization processDiscovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling.Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis.Biomarker discovery in asthma-related inflammation and remodeling.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Separation of propranolol enantiomers by CE using sulfated beta-CD derivatives in aqueous and non-aqueous electrolytes: comparative CE and NMR study.Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis.Enantiomeric separations of drugs using mixtures of charged and neutral cyclodextrins.Potential therapeutic target discovery by 2D-DIGE proteomic analysis in mouse models of asthma.The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioningDevelopmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring.High inorganic triphosphatase activities in bacteria and mammalian cells: identification of the enzymes involved.New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.Biomarkers of inflammation and innate immunity in atrophic nonunion fracture.Fluoxetine dose and administration method differentially affect hippocampal plasticity in adult female rats.The emergence of metabolomics as a key discipline in the drug discovery process.Subcellular mechanisms involved in apoptosis induced by aminoglycoside antibiotics: Insights on p53, proteasome and endoplasmic reticulum.Validation of a new method by nano-liquid chromatography on chip tandem mass spectrometry for combined quantitation of C3f and the V65 vitronectin fragment as biomarkers of diagnosis and severity of osteoarthritis.Capillary electrophoresis in the context of drug discovery.Development and validation of a LC method for the enantiomeric purity determination of S-ropivacaine in a pharmaceutical formulation using a recently commercialized cellulose-based chiral stationary phase and polar non-aqueous mobile phase.Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept.Quantitation and biospecific identification of virus-like particles of human papillomavirus by capillary electrophoresis.RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death.Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene.Separation of human, bovine, and porcine insulins, three very closely related proteins, by micellar electrokinetic chromatography.Study of intact virus-like particles of human papillomavirus by capillary electrophoresis.The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells.Effect of the nature of the single-isomer anionic CD and the BGE composition on the enantiomeric separation of beta-blockers in NACE.Unusual amino acids and monofluoroacetate from Dichapetalum michelsonii (Umutambasha), a toxic plant from Rwanda.Separation, identification and quantitation of ceramides in human cancer cells by liquid chromatography-electrospray ionization tandem mass spectrometry.Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis.Enhancement of selectivity and resolution in the enantioseparation of uncharged compounds using mixtures of oppositely charged cyclodextrins in capillary electrophoresis.Synergistic effects of ion-pairing in the enantiomeric separation of basic compounds with cyclodextrin derivatives in nonaqueous capillary electrophoresis.Prediction of selectivity for enantiomeric separations of uncharged compounds by capillary electrophoresis involving dual cyclodextrin systems.Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach.Enantiomeric separation of basic compounds using heptakis(2,3-di-O-methyl-6-O-sulfo)-beta-cyclodextrin in combination with potassium camphorsulfonate in nonaqueous capillary electrophoresis: optimization by means of an experimental design.
P50
Q24294648-2503AE93-1AD7-4923-B739-5610BF2689A2Q28168167-23320D7D-E48C-44B7-97D5-EB693DBB0247Q28975740-7E3A7344-7FF3-4EBD-94BB-5BF9D1004E2DQ33228253-783DED2E-7745-4806-A246-AD6F11369C61Q33270595-02E89982-E534-4C0E-A51F-DFB32B4A19B0Q33330803-A0D44837-480E-4198-BF9C-9BA9E7C58438Q33422354-CF796508-70BD-4A2B-9FF6-A21B99663F6DQ33520447-337C8895-90E2-4A7E-A3CA-B453860BA926Q33548396-CBB0D838-7AFA-4898-B59B-C8637EDE7915Q33833334-B77C51A4-ECE9-4FA1-B715-935C1336A3E9Q33934759-07DD4FC8-D5BE-4B9A-88D9-254558A11709Q33959728-DFE8FF1F-1FC7-4FA2-97EB-52E768BDADC8Q34045748-32ACF142-1A42-44FE-BAB9-7569FAF3B424Q34598248-0003A0B4-5A85-4882-BEA9-B492668C9B53Q34600630-57BD23FB-2368-4733-B61E-F751442501D2Q36229700-0E1860B5-B424-4502-86C7-C8AC060738D7Q37206175-44C52E38-A3FE-47C3-8ED8-BEAB4947EFEDQ37233069-73496D9C-A81E-4EAE-93F0-5340A13DF190Q37686866-8261C6AA-2620-4008-B8F2-B253172B9B97Q38550498-A690EC20-A75B-4D7B-9FD9-39E92619348FQ38749619-6475370B-1006-4E91-8AA9-42F529BA47F0Q38835871-1EB91A61-A874-4407-9FE8-4FD6CA3A7F2EQ39153076-2CCE05CF-70F0-477E-8E36-F5E50F2D9105Q39276190-9E26958A-5D94-429E-AD77-FFFE9568C20DQ39949092-97C30915-B7D4-4A14-86F7-E7CA5719FACEQ40070118-FC828171-9EEA-4FCC-A795-449F917DE5C6Q40421404-847C2AC0-1C7E-4BD1-BF5F-EDAA4CD60EA2Q40450520-BBD7A367-2EA7-4168-B5A2-E1D386054FC3Q40814803-E3C87567-9503-48BC-886D-933DE031B026Q41075053-86414F09-2B78-4E1D-AD42-8FCC1F01C3F3Q43286398-B66C208B-9ED2-4293-B7E4-5689037A8FDFQ43298510-9EA76B84-09A7-46F3-B827-8BA6178B3947Q43656279-662054B7-FE85-4412-8E81-120D9FB22E78Q43985878-6CF37218-2952-4A75-8187-94C919FA3138Q44062654-A30ED1EE-5518-430C-9608-18CA13F02B5FQ44304146-DAB2633A-6D3D-432C-95C2-658B017AC721Q44304149-80992C65-92F3-4F39-BB70-A8EA3D625AEDQ44494495-C0711C22-E42A-4D65-8A54-2B4EF146E4E6Q44801273-6413DF59-0E1F-4664-9609-0AE15A825B60Q45047600-C4CFCE89-F100-418B-8B84-62FF53EF5899
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marianne Fillet
@ast
Marianne Fillet
@en
Marianne Fillet
@es
Marianne Fillet
@nl
Marianne Fillet
@sl
type
label
Marianne Fillet
@ast
Marianne Fillet
@en
Marianne Fillet
@es
Marianne Fillet
@nl
Marianne Fillet
@sl
prefLabel
Marianne Fillet
@ast
Marianne Fillet
@en
Marianne Fillet
@es
Marianne Fillet
@nl
Marianne Fillet
@sl
P106
P1153
7003785094
P21
P31
P496
0000-0002-1453-6282